Position in BCRX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$431,122
+$260,279 QoQ
Shares Held
45,286
+106.8% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NAVELLIER & ASSOCIATES INC holds $7,785,437 across 2 Drug Manufacturers - Specialty & Generic names.
All Filings in BCRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $431,122 | 45,286 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $170,843 | 21,903 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $507,543 | 66,870 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $204,494 | 22,823 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||